Litigation Details for Bayer Intellectual Property GmbH v. Micro Labs Ltd. (D. Del. 2017)

Bayer Intellectual Property GmbH v. Micro Labs Ltd. (D. Del. 2017)

Docket		Date Filed	2017-05-12
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	9,539,218
Link to Docket	External link to docket

Details for Bayer Intellectual Property GmbH v. Micro Labs Ltd. (D. Del. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
2017-05-12	1		FDA. 22. U.S. Patent No. 9,539,218 (“the ’218 patent”), entitled “Prevention and Treatment…products prior to the expiration of U.S. Patent No. 9,539,218. Case 1:17-cv-00560-UNA Document 1 Filed… 1. This is an action for patent infringement under the patent laws of the United States, Title…forth in greater detail in the ’218 patent, the claims of the ’218 patent, incorporated by reference herein…the ’218 patent. 25. Bayer AG is an exclusive licensee under the ’218 patent.	External link to document
2017-05-12	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (crb) (Entered:… 12 May 2017 1:17-cv-00560 830 Patent None District Court, D. Delaware	External link to document
2017-07-17	9		23 PageID #: 39 United States Patent No. 9,539,218 (“the ‘218 patent”). Micro Labs admits that Micro…Paragraph 21. 22. U.S. Patent No. 9,539,218 (“the ‘218 patent”), entitled “Prevention and Treatment…or more claims of United States Patent No. 9,539,218 (“the ‘218 patent”) 3. Micro Labs USA…products prior to the expiration of U.S. Patent No. 9,539,218. ANSWER: Paragraph 1 contains… 1. This is an action for patent infringement under the patent laws of the United States, Title	External link to document